AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

Title
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
Authors
Keywords
Ghrelin, Type 2 diabetes, Insulin, Body weight, Obesity, Prader-Willi syndrome, Fats, Glucose
Journal
PLoS One
Volume 13, Issue 1, Pages e0190849
Publisher
Public Library of Science (PLoS)
Online
2018-01-11
DOI
10.1371/journal.pone.0190849

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started